Posterizan, rectal 10 pcs

Pharmacotherapeutic group: hemorrhoids treatment

ATC code: A07FA

Pharmacodynamics:

Antigens of cell walls and products of metabolism of Escherichia coli in contact with the mucosa of the rectum and the skin of the anogenital area increase local tissue resistance to pathogenic microflora.

The drug stimulates the T-lymphocytic system of cellular immunity Increases phagocytic activity of leukocytes and cells of the reticuloendothelial system Non-specific immune factors reduce vascular exudation during inflammation Normalizes the permeability and tone of blood vessels Stimulates regeneration of damaged tissues.

Indications

Posterizan rectal suppositories are prescribed to adults (from 18 years of age) for the following
diseases:
● anal itching;
● discharge and burning in the anal area due to
hemorrhoidal diseases.

Pharmacological effect

Pharmacotherapeutic group: hemorrhoids treatment

ATX code: A07FA

Pharmacodynamics:

Cell wall antigens and metabolic products of Escherichia coli upon contact with the rectal mucosa and skin of the anogenital area increase local tissue resistance to the effects of pathogenic microflora.

The drug stimulates the T-lymphocyte system of cellular immunity, increases the phagocytic activity of leukocytes and cells of the reticuloendothelial system, nonspecific immune factors reduces vascular exudation during inflammation, normalizes the permeability and tone of blood vessels, stimulates the regeneration of damaged tissues.

Special instructions

Impact on the ability to drive vehicles. Wed and fur.:

Posterizan® does not affect the ability to drive vehicles and perform work requiring an increased speed of psychomotor reactions.

Composition

1 suppository contains:

active ingredient: standardized bacterial culture suspension (SBC) of E. coli 387.10 mg (6.6 x 108 (4.95 x 108 – 8.25 x 108) micro cells of E. coli, inactivated and preserved in 6.6 mg of liquefied phenol);

excipients: liquefied phenol 6.60 mg (as part of SCR) (corresponding to the content of solid phenol 6.0 mg), solid fat 1603.22 mg, macrogol glycerol hydroxystearate 9.68 mg.

Contraindications

Hypersensitivity to the active substance or other components of the drug, children under 18 years of age.

Side Effects

Posterisan® has no side effects even with long-term use.

Phenol is used as a preservative in the drug; therefore, allergic reactions are possible in patients with hypersensitivity to this component, in the event of which the use of the drug should be discontinued.

Interaction

Drug interactions with Posterisan have not been described.

Overdose

No cases of overdose have been reported.
If accidentally swallowed (in children), gastrointestinal symptoms (abdominal pain, nausea) may occur.

Storage conditions

In a dry place, protected from light, at a temperature of 0 to 25 ° C.

Keep out of the reach of children.

Transportation

At temperatures from 0 to 25 °C.

Shelf life

3 years

Manufacturer

Dr. Kade, Germany